Skip to content

Screening and Treatment of SAHS in Patients With Acute Ischemic Stroke

Screening and Treatment of in Sleep Apnea Hypopnea Syndrome(SAHS)Patients With Acute Ischemic Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02029183
Acronym
SAHS
Enrollment
120
Registered
2014-01-07
Start date
2013-12-31
Completion date
2017-05-31
Last updated
2014-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke, Sleep Apnea Syndrome

Keywords

stroke, SAHS, BiPAP

Brief summary

Ischemic stroke is a kind of common disease with great harm. In acute stage of stroke there is sharply increasing morbidity of sleep apnea hypopnea syndrome. Our suppose that treatment with noninvasive ventilation for patients with acute ischemic stroke should improve the functional prognosis(measuring with 90d modified Rankin score).

Detailed description

In acute state of ischemic stroke,if patients with sleep apnea hypopnea syndrome may need additional respiratory management such bi-level positive airway pressure.We supposed the patients with stroke can take benefit of functional recovery form bi-level positive airway pressure. We choose the patients who suffered ischemic stroke in 48 hours ,then evaluate the respiratory status. Stroke patients who were diagnosed as sleep apnea hypopnea syndrome will accept additional treatment with bi-level positive airway pressure for 7 night(per night 6 hours).Then the modified Rankin scale score and NIHSS will be recorded at 30 days and 90 days after stroke.

Interventions

DEVICEBi level positive pressure ventilation

Bi level positive pressure ventilation should be given for subject for 6 hours per night ,total 7 times.

Sponsors

Peking University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* ischeic stroke onset within 48 hours , NIHSS:4-15

Exclusion criteria

* mRs\>2 before onset of enrollment severe hepatic renal insufficiency cancer in reached an advanced stage

Design outcomes

Primary

MeasureTime frameDescription
Modified Rankin Scale score90 days after symptoms0-2 Modified Rankin Scale score should be recognized good functional prognosis

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026